From Bedside to Animal Model to Therapies: Opportunities in Rare Diseases

Tuesday 6 May
8:45 to 10:45
CHEO Research Institute


Michael Smith Laboratories, University of British Columbia
Senior Director, Genetics, Xenon Pharmaceuticals
Strongly DisagreeDisagreeAgreeStrongly Agree
Overall appreciation of the session
The presentations were relevant to the scope of the session
The presenters provided knowledgeable and relevant information